Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	26288.41	2890.51	-10.95
Graham Fair Price	-97.35	0.13	4.99
PEG	-762792.99	-7.36	< 0.005
Price/Book	86.48	3.78	2.03
Price/Cash Flow	271.83	-330.86	88.98
Prices/Earnings	83806.56	735.00	0.88
Price/Sales	190.35	61.80	21.29
Price/FCF	271.83	-330.86	88.98
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	469.92	0.20	0.04
Operating Margin	-98.79	0.02	-1.27
ROA	-99.78	< 0.005	0.54
ROE	0.58	< 0.005	-99.78
ROIC	-0.12	< 0.005	-98.94
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.07	-1.00	-93.02
Dividends QOQ	1.57	-1.00	-36.22
EBIT QOQ	-1.79	1.01	-43.76
EPS QOQ	9.08	-1.00	-89.00
FCF QOQ	2.77	-1.50	-45.81
Revenue QOQ	-0.56	-0.36	36.17
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	184.81	358.39	93.92
Days Sales Outstanding (DSO)	52.35	14.36	-72.56
Inventory Turnover	0.49	0.25	-48.43
Debt/Capitalization	< 0.005	< 0.005	6.78
Quick Ratio	13.96	13.92	-0.32
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.38	0.78	-43.69
Cash	1.07	0.59	-44.65
Capex	< 0.005	< 0.005	89.24
Free Cash Flow	0.03	< 0.005	-71.76
Revenue	0.13	0.05	-63.84
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	17.18	18.36	6.87
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.71	-493.94	7261.37
Naive Interpretation	Member

06 - Financial Health · Bad

Rating